Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livia Lamartina

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|January 21, 2023
Randomised controlled trials are feasible in anaplastic thyroid cancerLivia Lamartina, Julien Hadoux
European Journal of Endocrinology|March 21, 2020
Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?Livia Lamartina, Daria Handkiewicz-Junak
Endocrine|January 11, 2015
Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of viewLivia Lamartina, David S Cooper
The Lancet. Diabetes & Endocrinology|January 22, 2021
Thyroid cancer incidence in children and adolescentsLivia Lamartina, Sophie Leboulleux, Martin Schlumberger
Annales D'Endocrinologie|February 9, 2024
Key data from the 2023 European Thyroid Association annual meeting: De-escalation strategy in diagnosis and the treatment of differentiated thyroid carcinoma: Update after the 2023 ETA congressMagalie Haissaguerre, Livia Lamartina, Philippe Caron
The Lancet. Diabetes & Endocrinology|March 10, 2022
Global thyroid estimates in 2020Livia Lamartina, Sophie Leboulleux, Isabelle Borget, et al.
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
European Thyroid Journal|January 10, 2022
Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancerStéphane Bardet, Renaud Ciappuccini, Livia Lamartina, et al.
European Journal of Endocrinology|June 3, 2016
ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approachLivia Lamartina, Désirée Deandreis, Cosimo Durante, et al.
Endocrinology and Metabolism Clinics of North America|July 27, 2025
Dosimetry in Advanced Thyroid Cancer: A Piece of a Puzzle?Carmela Nappi, Yann Cras, Livia Lamartina, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|January 21, 2023
Randomised controlled trials are feasible in anaplastic thyroid cancerLivia Lamartina, Julien Hadoux
European Journal of Endocrinology|March 21, 2020
Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?Livia Lamartina, Daria Handkiewicz-Junak
Endocrine|January 11, 2015
Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of viewLivia Lamartina, David S Cooper
The Lancet. Diabetes & Endocrinology|January 22, 2021
Thyroid cancer incidence in children and adolescentsLivia Lamartina, Sophie Leboulleux, Martin Schlumberger
Annales D'Endocrinologie|February 9, 2024
Key data from the 2023 European Thyroid Association annual meeting: De-escalation strategy in diagnosis and the treatment of differentiated thyroid carcinoma: Update after the 2023 ETA congressMagalie Haissaguerre, Livia Lamartina, Philippe Caron
The Lancet. Diabetes & Endocrinology|March 10, 2022
Global thyroid estimates in 2020Livia Lamartina, Sophie Leboulleux, Isabelle Borget, et al.
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
European Thyroid Journal|January 10, 2022
Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancerStéphane Bardet, Renaud Ciappuccini, Livia Lamartina, et al.
European Journal of Endocrinology|June 3, 2016
ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approachLivia Lamartina, Désirée Deandreis, Cosimo Durante, et al.
Endocrinology and Metabolism Clinics of North America|July 27, 2025
Dosimetry in Advanced Thyroid Cancer: A Piece of a Puzzle?Carmela Nappi, Yann Cras, Livia Lamartina, et al.
Pageof 11